Inventor · disambiguated record
Britton Kenneth Corkey
Also filed as: CORKEY BRITTON · CORKEY BRITTON K · CORKEY BRITTON KENNETH
31 granted patents·3 pending applications·295 citations·filing 2010–2025
97Inventor score
Top patents by PatentIndex Score
34 records- 0197US8378108B2Apoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2010·Granted Feb 19, 2013·58 cites·10 claims
- 0295US9067933B2Apoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2013·Granted Jun 30, 2015·25 cites·12 claims
- 0394US9371329B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2014·Granted Jun 21, 2016·26 cites·2 claims
- 0494US8952034B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2010·Granted Feb 10, 2015·29 cites·18 claims
- 0594US8598360B2Apoptosis signal-regulating kinase inhibitorsCORKEY BRITTON·Filed 2012·Granted Dec 3, 2013·20 cites·4 claims
- 0694US8586732B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Nov 19, 2013·29 cites·35 claims
- 0793US8440665B2Apoptosis signal-regulating kinase inhibitorsCORKEY BRITTON·Filed 2011·Granted May 14, 2013·21 cites·5 claims
- 0891US9676760B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 13, 2017·7 cites·2 claims
- 0991US9598435B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Mar 21, 2017·9 cites·13 claims
- 1091US9586932B2Apoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Mar 7, 2017·7 cites·4 claims
- 1190US9193694B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2013·Granted Nov 24, 2015·11 cites·11 claims
- 1289US9458145B2Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Oct 4, 2016·12 cites·9 claims
- 1388US8552196B2Apoptosis signal-regulating kinase inhibitorsCORKEY BRITTON·Filed 2012·Granted Oct 8, 2013·8 cites·10 claims
- 1487USRE48150EApoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2017·Granted Aug 11, 2020·2 cites·9 claims
- 1586USRE48711EApoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Aug 31, 2021·1 cites·10 claims
- 1684US9403782B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Aug 2, 2016·4 cites·10 claims
- 1783US9255089B2Benzimidazolone derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Feb 9, 2016·7 cites·19 claims
- 1882US11040033B2Therapeutic heterocyclic compoundsGILEAD SCIENCES INC·Filed 2018·Granted Jun 22, 2021·1 cites·22 claims
- 1982US8962610B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Feb 24, 2015·6 cites·21 claims
- 2081US9115096B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Aug 25, 2015·5 cites·13 claims
- 2180US8927582B2Apoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2013·Granted Jan 6, 2015·3 cites·6 claims
- 2279US9951065B2Benzimidazole and imadazopyridine carboximidamide compoundsGILEAD SCIENCES INC·Filed 2016·Granted Apr 24, 2018·3 cites·23 claims
- 2377US2025353820A1Antiviral pyrazolopyridinone compoundsNOVARTIS AG·Filed 2025·Application pending·0 cites
- 2473US9108953B2Quinoline derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Aug 18, 2015·1 cites·18 claims
- 2569US12338220B2Antiviral pyrazolopiridinone compoundsNOVARTIS AG·Filed 2023·Granted Jun 24, 2025·0 cites·21 claims
- 2663US11229638B2Therapeutic heterocyclic compoundsGILEAD SCIENCES INC·Filed 2018·Granted Jan 25, 2022·0 cites·7 claims
- 2762US2017196844A1Apoptosis signal-regulating kinase inhibitorsGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 2860US11667613B2Antiviral pyrazolopyridinone compoundsNOVARTIS AG·Filed 2020·Granted Jun 6, 2023·0 cites·38 claims
- 2955US2018282316A1Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 3052US10017501B2Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Jul 10, 2018·0 cites·15 claims
- 3151US9682998B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 20, 2017·0 cites·12 claims
- 3247US11186579B2Therapeutic heterocyclic compoundsGILEAD SCIENCES INC·Filed 2019·Granted Nov 30, 2021·0 cites·36 claims
- 3347US11098027B2Therapeutic heterocyclic compoundsGILEAD SCIENCES INC·Filed 2019·Granted Aug 24, 2021·0 cites·46 claims
- 3442US9695192B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Jul 4, 2017·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Britton Kenneth Corkey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →